Clinical Trials List
2009-02-01 - 2011-01-31
Phase II
Terminated3
ICD-10C78.00
Secondary malignant neoplasm of unspecified lung
ICD-10C78.01
Secondary malignant neoplasm of right lung
ICD-10C78.02
Secondary malignant neoplasm of left lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9197.0
Secondary malignant neoplasm of lung
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- JIN-YUAN SHIH Division of Thoracic Medicine
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- 陳冠宇 Division of Thoracic Medicine
- 林宗哲 Division of Hematology & Oncology
- Chong-Jen Yu Division of Thoracic Medicine
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chao-Hua Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
160 participants
